Review



cd40l-blocking antibody clone mr-1  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Bio X Cell cd40l-blocking antibody clone mr-1
    Cd40l Blocking Antibody Clone Mr 1, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd40l-blocking+antibody+clone+mr-1/anti+cd40l/pmc12017586-192-11-15
    Average 90 stars, based on 1 article reviews
    cd40l-blocking antibody clone mr-1 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Immunopeptidomics:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Blocking Assay:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    In Vivo:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Injection:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Comparison:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Labeling:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Membrane:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Transfection:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Incubation:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Flow Cytometry:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Expressing:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Cell Culture:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.

    Control:

    Article Title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.
    Article Snippet: For CD40L-blockade experiments in vivo, mice were injected intravenously with 200 μ g of CD40L-blocking antibody (clone MR-1, BioXCell) at the indicated times.

    Article Title: Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4 + T cell response
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) two hours prior to the first injection of substrate.

    Article Title: Identification of antigen-presenting cell-T cell interactions driving immune responses to food
    Article Snippet: For CD40L-blockade experiments, mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) 22 h prior to substrate injection.

    Article Title: Universal recording of cell–cell contacts in vivo for interaction-based transcriptomics
    Article Snippet: For CD40L and MHC Class II blocking experiments in vivo , mice were injected intravenously with 200 μg of CD40L-blocking antibody (clone MR-1, BioXCell) or subcutaneously with 150 μg of MHC-II (I-A/I-E) blocking antibody (clone M5/114, BioXCell), four hours prior to the first injection of substrate.



    Similar Products

    90
    Bio X Cell cd40l-blocking antibody clone mr-1
    Cd40l Blocking Antibody Clone Mr 1, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd40l-blocking+antibody+clone+mr-1/anti+cd40l/pmc12017586-192-11-15
    Average 90 stars, based on 1 article reviews
    cd40l-blocking antibody clone mr-1 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results